Literature DB >> 20403913

Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event?

Ketna Parekh1, Daniel Ching, Mahboob U Rahman, Lisa K Stamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20403913     DOI： 10.1093/rheumatology/keq101

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

Review 1.  Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far.

Authors:  Meghna Jani; William G Dixon; Hector Chinoy
Journal:  Rheumatology (Oxford)       Date:  2018-11-01       Impact factor: 7.580

Review 2.  Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Cheng-Hua Weng; Zhi-Chun Liu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

Review 3.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

4.  Clinical use of biologics in vasculitis syndromes.

Authors:  Marino Paroli
Journal:  Biologics       Date:  2012-10-25

Review 5.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686

6.  Developing of Granulomatosis with Polyangiitis during Etanercept Therapy.

Authors:  María Clara Ortiz-Sierra; Andrés Felipe Echeverri; Gabriel J Tobón; Carlos Alberto Cañas
Journal:  Case Rep Rheumatol       Date:  2014-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.